EUVIMEDOpdag EUVIMED
Leserbrief

Beyond the Viroporin: The Envelope Protein as a Therapeutic Target in Viral Immunomodulation

DuJiang Yang, GuoYou Wang iD

Reviews in Medical Virology · 2025

DOI: 10.1002/rmv.70076 ↗

At a glance

Leserbrief in Reviews in Medical Virology, 2025. Written by DuJiang Yang and 1 co-authors. Institution: The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China. Major MEDLINE topics: Immunomodulation, Viral Envelope Proteins, Virus Diseases. Cited 1 times so far (Crossref); 5 references. Funded by: The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

In their comprehensive review, Shekhar et al. (Rev Med Virol. 2025; 35:e70067) provide a valuable synthesis of the viral envelope (E) protein's role in subverting innate immunity and its potential as a pharmacological target. While we commend this timely work, our letter offers a critical perspective on the translational challenges and complexities that warrant deeper consideration. We argue that the context‐dependent functionality of the E protein—wherein its immunomodulatory effects vary with infection stage, cell type, and viral load—poses a significant hurdle for therapeutic intervention, potentially limiting the efficacy of direct viroporin inhibitors. Furthermore, we highlight emerging mechanisms beyond those extensively covered, such as the E protein's role in inducing ER stress‐mediated cellular dysfunction and its newly discovered capacity to degrade STAT2 via selective autophagy, thereby broadly suppressing interferon signaling. The structural intractability of the small, oligomeric E protein to conventional small‐molecule drugs is another substantial barrier, shifting the focus towards host‐directed therapies. Finally, we critically examine the evolutionary dynamics of this conserved target, emphasizing the need for combination strategies to preempt resistance. This critique aims to refine the roadmap for future research by underscoring the necessity for a nuanced, mechanism‐driven, and translationally‐aware approach to targeting the E protein.

Subjects

MeSH terms (MEDLINE)

ImmunomodulationViral Envelope ProteinsVirus DiseasesAnimalsHumansAntiviral AgentsAutophagyImmunity, InnateReview Literature as Topic

Substances

Antiviral AgentsViral Envelope Proteins

Authors and institutions

  • The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China.

ORCID profiles: GuoYou Wang

Funding

  • The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University

Cite

APA

Yang, D., & Wang, G. (2025). Beyond the Viroporin: The Envelope Protein as a Therapeutic Target in Viral Immunomodulation. Reviews in Medical Virology. https://doi.org/10.1002/rmv.70076

Vancouver

Yang D, Wang G. Beyond the Viroporin: The Envelope Protein as a Therapeutic Target in Viral Immunomodulation. Reviews in Medical Virology. 2025. doi:10.1002/rmv.70076

BibTeX
@article{Yang2025,
  author = {Yang, DuJiang and Wang, GuoYou},
  title = {Beyond the Viroporin: The Envelope Protein as a Therapeutic Target in Viral Immunomodulation},
  journal = {Reviews in Medical Virology},
  year = {2025},
  doi = {10.1002/rmv.70076}
}
Start for free →